Soleus Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-870,000
| Closed | -$2.85M | – | 90 |
|
|
2024
Q2 | $2.85M | Hold |
870,000
| – | – | 0.25% | 73 |
|
|
2024
Q1 | $6.39M | Buy |
+870,000
| New | +$6.39M | 0.47% | 57 |
|
|
2022
Q4 | – | Sell |
-67,300
| Closed | -$1.51M | – | 78 |
|
|
2022
Q3 | $1.51M | Sell |
67,300
-127,100
| -65% | -$2.85M | 0.2% | 62 |
|
|
2022
Q2 | $4.82M | Sell |
194,400
-11,500
| -6% | -$285K | 0.75% | 39 |
|
|
2022
Q1 | $7.98M | Buy |
205,900
+198,100
| +2,540% | +$7.68M | 1.03% | 31 |
|
|
2021
Q4 | $456K | Buy |
+7,800
| New | +$456K | 0.05% | 62 |
|
|
2021
Q1 | – | Sell |
-6,830
| Closed | -$621K | – | 77 |
|
|
2020
Q4 | $621K | Sell |
6,830
-2,882
| -30% | -$262K | 0.08% | 59 |
|
|
2020
Q3 | $388K | Sell |
9,712
-23,288
| -71% | -$930K | 0.21% | 57 |
|
|
2020
Q2 | $1.13M | Buy |
+33,000
| New | +$1.13M | 0.65% | 36 |
|
|
2020
Q1 | – | Sell |
-11,400
| Closed | -$223K | – | 53 |
|
|
2019
Q4 | $223K | Buy |
+11,400
| New | +$223K | 0.22% | 48 |
|